Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Petechiae; Bleeding gastrointestinal; Intracardiac thrombus; Haematoma; This is a spontaneous report received from a non-contactable physician downloaded from the regulatory authority-WEB, regulatory authority number DE-PEI-202100064228. A 61-year-old female patient received bnt162b2 (COMIRNATY), via unspecified route of administration on 27Apr2021 (lot number: unknown) at single dose for COVID-19 immunisation. The relevant medical history included ongoing alcohol abuse, ongoing mitral valve stenosis, ongoing arterial hypertension, ongoing hepatic cirrhosis, ongoing diabetes mellitus and ongoing anemia. Concomitant medications were not reported. On 09May2021 the patient experienced intracardiac thrombus, petechiae, haematoma, bleeding gastrointestinal. The events were reported as serious due to death. The patient died on 09May2021. It was unknown if an autopsy was performed. The outcome of the events was fatal. Relatedness of drug to reaction/event (for all events), Source of assessment: regulatory authority, Result of Assessment reported as D. Unclassifiable. No follow-up attempts are possible. Information about batch/lot number cannot be obtained.; Reported Cause(s) of Death: Petechiae; Bleeding gastrointestinal; Haematoma; Intracardiac thrombus
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166